4685 related items for PubMed ID: 16487444
1. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C.
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[Abstract] [Full Text] [Related]
2. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[Abstract] [Full Text] [Related]
3. Blood coagulation and fibrinolytic activity in hypothyroidism.
Erem C, Kavgaci H, Ersöz HO, Hacihasanoglu A, Ukinç K, Karti SS, Deger O, Telatari M.
Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786
[Abstract] [Full Text] [Related]
4. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
Erem C, Ersoz HO, Karti SS, Ukinç K, Hacihasanoglu A, Değer O, Telatar M.
J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
[Abstract] [Full Text] [Related]
5. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
Erem C, Hacihasanoğlu A, Celik S, Ovali E, Ersöz HO, Ukinç K, Deger O, Telatar M.
Med Princ Pract; 2005 Apr; 14(1):22-30. PubMed ID: 15608477
[Abstract] [Full Text] [Related]
6. [Plasma haemostatic and fibrinolytic activities and their relationship to levels of serum lipids and apolipoproteins in endogenous hypertriglyceridemic patients].
Shen T, Bai H, Liu B, Liu Y, Zhang Z, Deng Z.
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):405-8. PubMed ID: 12910674
[Abstract] [Full Text] [Related]
7. Blood coagulation and fibrinolysis in male patients with hypogonadotropic hypogonadism: plasma factor V and factor X activities increase in hypogonadotropic hypogonadism.
Erem C, Kocak M, Hacihasanoglu A, Yilmaz M.
J Endocrinol Invest; 2008 Jun; 31(6):537-41. PubMed ID: 18591887
[Abstract] [Full Text] [Related]
8. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T, Rauramaa R, Väisänen S, Penttilä IM, Uusitupa M.
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[Abstract] [Full Text] [Related]
9. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[Abstract] [Full Text] [Related]
10. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR.
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[Abstract] [Full Text] [Related]
11. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
Exp Clin Endocrinol Diabetes; 2000 Apr; 108(7):486-92. PubMed ID: 11083070
[Abstract] [Full Text] [Related]
12. Relationship between thyroid hormones and plasma D-dimer levels.
Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G.
Thromb Haemost; 1998 Jan; 79(1):99-103. PubMed ID: 9459332
[Abstract] [Full Text] [Related]
13. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S.
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[Abstract] [Full Text] [Related]
14. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A, Nagy EV, Burman KD, Paragh G, Jenei Z.
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[Abstract] [Full Text] [Related]
15. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
Menopause; 2006 Jun; 13(4):643-50. PubMed ID: 16837886
[Abstract] [Full Text] [Related]
16. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE, Törüner FB, Aktürk M, Bukan N, Cakir N, Ayvaz G, Arslan M.
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[Abstract] [Full Text] [Related]
17. Dyslipidemias and fibrinolysis.
Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Auteri A.
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[Abstract] [Full Text] [Related]
18. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I.
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[Abstract] [Full Text] [Related]
19. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A, Ruusuvaara L.
Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
[Abstract] [Full Text] [Related]
20. Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
Pineda J, Marín F, Marco P, Roldán V, Valencia J, Ruiz-Nodar JM, Sogorb F, Lip GY.
Int J Cardiol; 2009 Aug 14; 136(2):222-5. PubMed ID: 18625524
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
